SCHEMBL22472452

SCHEMBL22472452

Cc1ccc2c(oc3nc4ccccc4n32)c1-c1ccc(-c2cc(-c3ccccc3)c(-c3ccccc3)cc2-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.40
ALDH1A1 P00352 8/20 0.40
HPGD P15428 5/20 0.40
GAA P10253 3/20 0.40
MAPK1 P28482 1/20 0.40
ADORA2A P29274 1/20 0.38
MDM2 Q00987 1/20 0.36
POLB P06746 4/20 0.36
HSD17B10 Q99714 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NUDT1 P36639 1/20 0.36
LMNA P02545 4/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MAPT P10636 4/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22472385 0.93 ADORA2A (0.40) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22472471 0.85 ALDH1A1 (0.38) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22472470 0.80 ALDH1A1 (0.37) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22472388 0.78 KDM4E (0.34) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL17507336 0.77 HPGD (0.40) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL17507333 0.77 HPGD (0.42) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22472473 0.76 MAT2A (0.32) MEN1KMT2ANUDT1NPC1RAB9A
SCHEMBL22472396 0.76 ALDH1A1 (0.34) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL20041619 0.75 TP53 (0.43) HPGDRXFP1MAPTSMN1; SMN2TDP1
SCHEMBL25592764 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790455-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790455-B2 Organic electroluminescent materials and devices ORC3, ALKBH2, ENPP3 KDM4E 1498/4885ALDH1A1 2253/4885HPGD 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.